Drug Trial Radar · NCT06145893
A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
Last checked: Nov 19, 2026Latest source record: Apr 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
162
Planned (sponsor's estimate)
Start
Nov 13, 2023
Primary completion
May 30, 2026
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- Ganzhou Hemay Pharmaceutical Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Nov 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 3, multi-center, randomized, placebo-controlled, double-blind, parallel-group study with an equal randomization among the Hemay005 high dose, lower dose and placebo treatment groups. After subject randomization, each subject will enter an core-treatment Phase for 12 weeks following an extended-treatment phase for another 40 weeks and a follow up phase for 4weeks.
Conditions
- Behçet's Disease
Interventions
Hemay005Drug
Hemay005 tables 60mg bid p.o;
Hemay005Drug
Hemay005 tables 45mg bid p.o;
PlaceboDrug
placebo to Hemay005 tables bid p.o
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy assessed by oral ulcersTime frame: week 12
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
The first affiliated hospital of Wenzhou Medical university
Wenzhou, China · Recruiting
Beijing Friendship hospital capital medical hospital
Beijing, Beijing Municipality, China · Recruiting
Peking university first hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University People's Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking university third hospital
Beijing, Beijing Municipality, China · Recruiting
Xuanwu hospital capital medical university
Beijing, Beijing Municipality, China · Recruiting
The first affiliated hospital of Xiamen University
Xiamen, Fujian, China · Recruiting
Guangdong second provincial central hospital
Guangzhou, Guangdong, China · Recruiting
Sun Yat-Sen memorial hospital
Guangzhou, Guangdong, China · Recruiting
The third affiliated hospital sun yat-sen university
Guangzhou, Guangdong, China · Recruiting
The university of Hong Kong-Shenzhen Hospital
Shenzhen, Guangdong, China · Recruiting
Affiliated hospital of Guilin Medical university
Guilin, Guangxi, China · Recruiting
The second hospital of Hebei medical university
Shijiazhuang, Hebei, China · Not yet recruiting
Xinxiang Central hospital
Xinxiang, Henan, China · Recruiting
The first affiliated hospital of Nanchang university
Nanchang, Jiangsu, China · Recruiting
The first affiliated hospital of Soochow university
Suzhou, Jiangsu, China · Recruiting
The affiliated hospital of Xuzhou medical university
Xuzhou, Jiangsu, China · Recruiting
Jilin Province People's hospital
Changchun, Jilin, China · Recruiting
Linyi People's Hospital
Linyi, Shandong, China · Not yet recruiting
Tongji hospital of Tongji university
Shanghai, Shanghai Municipality, China · Recruiting
Second hospital of shanxi medical university
Taiyuan, Shanxi, China · Not yet recruiting
The first affiliated hospital, Zhejiang University school of medicine
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.